Natus Medical Inc (NTUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 13,177 | -16,613 | -15,671 | -22,935 | -20,293 |
| Depreciation Amortization | 28,091 | 28,115 | 30,722 | 48,709 | 30,098 |
| Income taxes - deferred | -4,386 | -1,577 | -5,364 | -13,714 | 4,032 |
| Accounts receivable | -13,111 | 17,651 | 7,139 | -5,199 | -30,473 |
| Accounts payable and accrued liabilities | 13,530 | -4,523 | -1,367 | 4,105 | -1,385 |
| Other Working Capital | 7,320 | 1,423 | 9,853 | -14,106 | -20,596 |
| Other Operating Activity | 19,374 | 9,950 | 34,748 | 36,160 | 58,343 |
| Operating Cash Flow | $63,995 | $34,426 | $60,060 | $33,020 | $19,726 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,000 | -2,000 | N/A | N/A | 34,019 |
| PPE Investments | -946 | -8,609 | -5,326 | -7,875 | -4,066 |
| Net Acquisitions | N/A | -1,997 | N/A | 151 | -190,888 |
| Purchase Sale Intangibles | N/A | N/A | -13 | -665 | N/A |
| Other Investing Activity | 0 | 0 | -13 | -665 | 0 |
| Investing Cash Flow | $-1,946 | $-12,606 | $-5,339 | $-8,389 | $-160,935 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | 60,000 | 0 | 0 | 60,000 |
| Debt Repayment | -57,410 | -58,527 | -50,478 | -50,000 | -45,000 |
| Common Stock Issued | 855 | 1,314 | 3,635 | 11,448 | 3,466 |
| Common Stock Repurchased | N/A | -10,495 | N/A | -5,630 | -2,268 |
| Other Financing Activity | -4,107 | -3,169 | -1,689 | -5,330 | -10,372 |
| Financing Cash Flow | $-60,662 | $-10,877 | $-48,532 | $-49,512 | $5,826 |
| Exchange Rate Effect | -7,874 | 7,842 | 735 | -7,696 | 10,782 |
| Beginning Cash Position | 82,082 | 63,297 | 56,373 | 88,950 | 213,551 |
| End Cash Position | 75,595 | 82,082 | 63,297 | 56,373 | 88,950 |
| Net Cash Flow | $-6,487 | $18,785 | $6,924 | $-32,577 | $-124,601 |
| Free Cash Flow | |||||
| Operating Cash Flow | 63,995 | 34,426 | 60,060 | 33,020 | 19,726 |
| Capital Expenditure | -3,620 | -8,609 | -5,326 | -7,875 | -4,066 |
| Free Cash Flow | 60,375 | 25,817 | 54,734 | 25,145 | 15,660 |